![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
,2
* Laboratory of Molecular Genetics and
Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021
2To whom correspondence should be addressed. E-mail: friedj{at}mail.rockefeller.edu.
The incidence of obesity has increased sharply in recent years, making it one of the most urgent public health concerns worldwide. The hormone leptin is the central mediator in a negative feedback loop regulating energy homeostasis. Leptin administration leads to reduced food intake, increased energy expenditure, and weight loss. Leptin also mediates unique metabolic effects, specifically depleting lipid from liver and other peripheral tissues. While elucidation of leptin’s role has permitted a more detailed view of the biology underlying energy homeostasis, most obese individuals are leptin resistant. A more complete understanding of the molecular components of the leptin pathway is necessary to develop effective treatment for obesity and the Metabolic Syndrome. We review here studies on the identification of one such component, stearoyl-CoA desaturase-1 (SCD-1), as a gene specifically repressed by leptin and discuss the role of this process in mediating the metabolic effects of leptin. Data indicate that pharmacologic manipulation of SCD-1 may be of benefit in the treatment of obesity, diabetes, hepatic steatosis, and other components of the Metabolic Syndrome.
KEY WORDS: • leptin • obesity • Metabolic Syndrome • stearoyl-CoA desaturase
This article has been cited by other articles:
|
|
 |
|
  V. Kus, T. Prazak, P. Brauner, M. Hensler, O. Kuda, P. Flachs, P. Janovska, D. Medrikova, M. Rossmeisl, Z. Jilkova, et al. Induction of muscle thermogenesis by high-fat diet in mice: association with obesity-resistance Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E356 - E367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mar-Heyming, M. Miyazaki, D. Weissglas-Volkov, N. A. Kolaitis, N. Sadaat, C. Plaisier, P. Pajukanta, R. M. Cantor, T. W.A. de Bruin, J. M. Ntambi, et al. Association of Stearoyl-CoA Desaturase 1 Activity With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1193 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lai, G. Bikopoulos, M. B. Wheeler, M. Rozakis-Adcock, and A. Volchuk Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E540 - E550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Beltrand, M. Beregszaszi, D. Chevenne, G. Sebag, M. De Kerdanet, F. Huet, M. Polak, N. Tubiana-Rufi, D. Lacombe, A. M. De Paoli, et al. Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy Pediatrics, August 1, 2007; 120(2): e291 - e296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hajri, A. M. Hall, D. R. Jensen, T. A. Pietka, V. A. Drover, H. Tao, R. Eckel, and N. A. Abumrad CD36-Facilitated Fatty Acid Uptake Inhibits Leptin Production and Signaling in Adipose Tissue Diabetes, July 1, 2007; 56(7): 1872 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dridi, M. Taouis, A. Gertler, E. Decuypere, and J. Buyse The regulation of stearoyl-CoA desaturase gene expression is tissue specific in chickens J. Endocrinol., January 1, 2007; 192(1): 229 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fishman, R. H. Muzumdar, G. Atzmon, X. Ma, X. Yang, F. H. Einstein, and N. Barzilai Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo FASEB J, January 1, 2007; 21(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Pilch and N. Bergenhem Pharmacological Targeting of Adipocytes/Fat Metabolism for Treatment of Obesity and Diabetes Mol. Pharmacol., September 1, 2006; 70(3): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kraft, L. Hanske, P. Mockel, S. Zimmermann, A. Hartl, J. K. G. Kramer, and G. Jahreis The Conversion Efficiency of trans-11 and trans-12 18:1 by {Delta}9-Desaturation Differs in Rats J. Nutr., May 1, 2006; 136(5): 1209 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bjursell, A.-K. Gerdin, K. Ploj, D. Svensson, L. Svensson, J. Oscarsson, M. Snaith, J. Tornell, and M. Bohlooly-Y Melanin-Concentrating Hormone Receptor 1 Deficiency Increases Insulin Sensitivity in Obese Leptin-Deficient Mice Without Affecting Body Weight Diabetes, March 1, 2006; 55(3): 725 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C L. Kien, J. Y Bunn, and F. Ugrasbul Increasing dietary palmitic acid decreases fat oxidation and daily energy expenditure Am. J. Clinical Nutrition, August 1, 2005; 82(2): 320 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Valtuena, F. Numeroso, D. Ardigo, M. Pedrazzoni, L. Franzini, P. M. Piatti, L. Monti, and I. Zavaroni Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels Eur. J. Endocrinol., August 1, 2005; 153(2): 283 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cohen, G. Yang, X. Yu, A. A. Soukas, C. S. Wolfish, J. M. Friedman, and C. Li Induction of Leptin Receptor Expression in the Liver by Leptin and Food Deprivation J. Biol. Chem., March 18, 2005; 280(11): 10034 - 10039. [Abstract] [Full Text] [PDF]
|
|
